drugset / Trial / NCT00825500
Staccato Loxapine in Migraine (Out Patient)
RandomizedParallel-groupTriple-blindTreatment
Summary
Assess the safety and efficacy of Staccato Loxapine in patients with moderate to severe migraine headache with or without aura in an outpatient setting.
Timeline
- Start
- 2009-01
- Primary completion
- 2009-08
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | loxapine | Small molecule | 1.25 mg | Inhaled |
| Comparator | loxapine | Small molecule | 2.5 mg | Inhaled |